Literature DB >> 6269425

Fever in renal transplant recipients: causes, prognostic significance and changing patterns at the University of Minnesota Hospital.

P K Peterson, H H Balfour, D S Fryd, R M Ferguson, R L Simmons.   

Abstract

During a three year period in which 433 renal transplants were performed, 194 episodes of fever were documented in allograft recipients hospitalized at the University of Minnesota. Viral infections were responsible for over half of the febrile episodes, and 98 (51 percent) of the fevers were associated with cytomegalovirus (CMV), either occurring alone or in conjunction with allograft rejection or another systemic infection. Bacterial infections, fungal infections and rejection were other important causes of fever, accounting for 14 percent, 5 percent and 13 percent of the febrile episodes, respectively. Most fevers occurred in the first four months after transplantation; although about two thirds of these fevers were due to CMV, only 17 percent of fevers that occurred more than one year after the renal transplant were due to CMV. Bacterial and fungal infections and malignancy were important causes of these fevers. Of the febrile illnesses associated with transplant nephrectomy or death, a majority occurred in patients with CMV disease. Secondary bacterial and/or fungal infections were observed in a large majority of patients with lethal CMV disease. During the third year of this study there was a significant decrease in the proportion of febrile episodes due to CMV.

Entities:  

Mesh:

Year:  1981        PMID: 6269425     DOI: 10.1016/0002-9343(81)90149-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Endocarditis by Aspergillus fumigatus in a renal transplant.

Authors:  P Marín; P García-Martos; A García-Doncel; A García-Tapia; E Aznar; J Perez Requena; S Valverde
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.

Authors:  C V Fletcher; J A Englund; C K Edelman; C R Gross; D L Dunn; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Pulmonary cavitation with Nocardia and Aspergillus in a renal transplant patient.

Authors:  J M Carter; W R Green; C O Callender; B Peters
Journal:  J Natl Med Assoc       Date:  1990-07       Impact factor: 1.798

Review 4.  Aspergillosis.

Authors:  G P Bodey; S Vartivarian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

Review 5.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

6.  CNS aspergillosis in organ transplantation: a clinicopathological study.

Authors:  J Torre-Cisneros; O L Lopez; S Kusne; A J Martinez; T E Starzl; R L Simmons; M Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

Review 7.  Prevention of cytomegalovirus infection in the pediatric renal transplant recipient.

Authors:  P L Hibberd; R H Rubin
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 8.  Management of children after renal transplantation: highlights for general pediatricians.

Authors:  Keith K Lau; Lucy Giglia; Howard Chan; Anthony K Chan
Journal:  Transl Pediatr       Date:  2012-07

9.  Spectrum of pulmonary infections in renal transplant recipients in the tropics: a single center study.

Authors:  Vikram Kalra; Sanjay Kumar Agarwal; Gopi Chand Khilnani; Arti Kapil; Lalit Dar; Urvashi B Singh; Bijay Ranjan Mirdha; Immaculata Xess; Sanjay Gupta; Dipankar Bhowmik; Suresh Chand Tiwari; Suresh Chand Dash
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.266

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.